Michael A Carducci


If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael A Carducci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., Gaver, M., Wang, H., Denmeade, S., Lotan, T., Paller, C., Markowski, M., Carducci, M., Eisenberger, M., Beer, T. M., Song, D. Y., Deweese, T. L., Hearn, J. W., Greco, S., Deville, C. & 7 others, Desai, N. B., Heath, E. I., Liauw, S., Spratt, D. E., Hung, A. Y., Antonarakis, E. S. & Tran, P. T., Jun 13 2019, In : BMC cancer. 19, 1, 572.

Research output: Contribution to journalArticle

Open Access
Salvage Therapy
Double-Blind Method
Prostatic Neoplasms

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: The CheckMate 016 study (Journal for ImmunoTherapy of Cancer (2018) 6 (109) DOI: 10.1186/s40425-018-0420-0)

Amin, A., Plimack, E. R., Ernstoff, M. S., Lewis, L. D., Bauer, T. M., McDermott, D. F., Carducci, M. A., Kollmannsberger, C., Rini, B. I., Heng, D. Y. C., Knox, J., Voss, M. H., Spratlin, J., Berghorn, E., Yang, L. & Hammers, H. J., Mar 14 2019, In : Journal for immunotherapy of cancer. 7, 1, 73.

Research output: Contribution to journalComment/debate

Open Access
Renal Cell Carcinoma

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype

Shenderov, E., Isaacsson Velho, P., Awan, A. H., Wang, H., Mirkheshti, N., Lotan, T. L., Carducci, M. A., Pardoll, D. M., Eisenberger, M. A. & Antonarakis, E. S., Jan 1 2019, In : Prostate. 79, 13, p. 1572-1579 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Prostate-Specific Antigen
Renal Cell Carcinoma
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
Prospective Studies
Neoplasm Metastasis

Metastatic Hormone-Sensitive Prostate Cancer: Clinical Decision Making in a Rapidly Evolving Landscape of Life-Prolonging Therapy

VanderWeele, D. J., Antonarakis, E. S., Carducci, M. A., Dreicer, R., Fizazi, K., Gillessen, S., Higano, C. S., Morgans, A. K., Petrylak, D. P., Sweeney, C. J. & Hussain, M., Nov 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 32, p. 2961-2967 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Clinical Decision-Making